Quarterly report pursuant to Section 13 or 15(d)

Cash, Cash Equivalents and Short-Term Investments (Tables)

v3.23.1
Cash, Cash Equivalents and Short-Term Investments (Tables)
 3 Months Ended
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Cash, Cash Equivalents and Restricted Cash
Cash, cash equivalents and restricted cash were as follows (in millions):
As of
March 31,
2023		 December 31,
2022
Cash and cash equivalents $ 175  $ 262 
Restricted cash, long-term (a)
20  15 
Total cash, cash equivalents and restricted cash
 $ 195  $ 277 
(a) Included in Other assets on the consolidated balance sheets
Schedule of Cash, Cash Equivalents and Restricted Cash
Cash, cash equivalents and restricted cash were as follows (in millions):
As of
March 31,
2023		 December 31,
2022
Cash and cash equivalents $ 175  $ 262 
Restricted cash, long-term (a)
20  15 
Total cash, cash equivalents and restricted cash
 $ 195  $ 277 
(a) Included in Other assets on the consolidated balance sheets
Schedule of Fair Value, Assets Measured on Recurring Basis
The components of cash equivalents and short-term investments measured at fair value on a recurring basis were as follows (in millions):
As of
Fair value level March 31,
2023		 December 31,
2022
Cash equivalents:
Money market funds
 Level 1 $ 149  $ 204 
U.S. Treasury securities
 Level 2 25  57 
Total cash equivalents
 $ 174  $ 261 
Short-term investments:
U.S. Treasury securities
 Level 2 $ 791  $ 839 
Total short-term investments $ 791  $ 839 
Schedule of U.S Treasury Securities , Amortized Costs and Fair Value
The amortized cost, unrealized gains and losses, and fair value of available-for-sale debt securities were as follows (in millions):
As of March 31, 2023
Amortized cost Unrealized losses Fair value
U.S. Treasury securities $ 792  $ (1) $ 791 
As of December 31, 2022
Amortized cost Unrealized losses Fair value
U.S. Treasury securities $ 841  $ (2) $ 839